Moreover, carriers of pathogenic NF1 variants exhibit a significantly increased risk of breast cancer in early to mid-adulthood, particularly between ages 30 and 50, whereas a possible elevation in cumulative lifetime risk, estimated at about twofold compared with the general population, remains uncertain [36, 98, 99]. Here, NF1 is linked to breast carcinoma.